The Next Fed Chair Ran Money for Stanley Druckenmiller. Here's Why That Matters.
Plus: Warsh's $100M+ Druckenmiller fund, his Palantir and crypto holdings, why his AI productivity thesis could unlock rate cuts, and what this means for every ticker the family owns.
Ozempic Was Just the Opening Act. Peptides Are the Show.
Plus TSMC rips on 58% profit jump and $52B capex guide, Microsoft surges on Azure AI breakthrough, quantum computing has its best week in years, and yesterday's S&P 7,000 milestone was not the top.